Chaiwat Aphivatanasiri

Dr. Chaiwat Aphivatanasiri

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 June 2022 in HPB
Verified
Journal Article
Open access
PSPrakasit Sa-Ngiamwibool
Prakasit Sa-Ngiamwibool
CAChaiwat Aphivatanasiri
Chaiwat Aphivatanasiri
SSSakkarn Sangkhamanon
Sakkarn Sangkhamanon
PIPiyapharom Intarawichian
Piyapharom Intarawichian
WKWaritta Kunprom
Waritta Kunprom
SKSupinda Koonmee
Supinda Koonmee
Intrahepatic cholangiocarcinoma (iCCA) arises from bile ducts within the liver. Thailand has the highest incidence of CCA worldwide, with a high mortality rate. Early diagnosis and accurate prognostic stratification can improve overall survival. We aim to modify the AJCC/UICC 8th edition staging system for iCCA by creating the Khon Kaen University (KKU) staging system for more precise patient stratification and prognostic prediction. A total of 298 iCCA patients who underwent hepatectomy were included in this retrospective study at the Srinagarind Hospital, Khon Kaen University, Thailand. Univariate and multivariate analysis were performed to examine survival rate, hazard ratio, and prognostic factors. Univariate and multivariate analysis of the cohort showed that growth patterns, histological type, histological grade, lymph node metastasis and distant metastasis were independent prognostic factors when compared to the respective reference groups. The 8th AJCC staging system incorporated growth patterns into the KKU staging system. This model modified AJCC stages I, II, and III for better prediction of patient survival. Growth patterns were incorporated to improve the 8th AJCC staging system for prognostication of iCCA patients in Northeast Thailand. We propose the KKU staging system as an alternative model for iCCA staging to augment the accuracy of survival prognostication.

2 October 2023 in Cancers
Verified
Journal Article
Open access
PDF file
NKNatcha Khuntikeo
Natcha Khuntikeo
SPSureerat Padthaisong
Sureerat Padthaisong
WLWatcharin Loilome
Watcharin Loilome
PKPoramate Klanrit
Poramate Klanrit
SRSoontaree Ratchatapusit
Soontaree Ratchatapusit
ATAttapol Titapun
Attapol Titapun
Background: The mismatch repair (MMR) system prevents DNA mutation; therefore, deficient MMR protein (dMMR) expression causes genetic alterations and microsatellite instability (MSI). dMMR is correlated with a good outcome and treatment response in various cancers; however, the situation remains ambiguous in cholangiocarcinoma (CCA). This study aims to evaluate the prevalence of dMMR and investigate the correlation with clinicopathological features and the survival of CCA patients after resection. Materials and Methods: Serum and tissues were collected from CCA patients who underwent resection from January 2005 to December 2017. Serum OV IgG was examined using ELISA. The expression of MMR proteins MLH1, MSH2, MSH6 and PMS2 was investigated by immunohistochemistry; subsequently, MMR assessment was evaluated as either proficient or as deficient by pathologists. The clinicopathological features and MMR status were compared using the Chi-square test. Univariate and multivariate analyses were conducted to identify prognostic factors. Results: Among the 102 CCA patients, dMMR was detected in 22.5%. Survival analysis revealed that dMMR patients had better survival than pMMR (HR = 0.50, p = 0.008). In multivariate analysis, dMMR was an independent factor for a good prognosis in CCA patients (HR = 0.58, p = 0.041), especially at an early stage (HR = 0.18, p = 0.027). Moreover, subgroup analysis showed dMMR patients who received adjuvant chemotherapy had better survival than surgery alone (HR = 0.28, p = 0.012). Conclusion: This study showed a high prevalence of dMMR in cholangiocarcinoma with dMMR being the independent prognostic factor for good survival, especially in early-stage CCA and for patients who received adjuvant chemotherapy. dMMR should be the marker for selecting patients to receive a specific adjuvant treatment after resection for CCA.

13 December 2022 in Frontiers in Oncology
Verified
Journal Article
Open access
PIPiyapharom Intarawichian
Piyapharom Intarawichian
SSSirada Sangpaibool
Sirada Sangpaibool
PPPiya Prajumwongs
Piya Prajumwongs
PSPrakasit Sa-Ngiamwibool
Prakasit Sa-Ngiamwibool
SSSakkarn Sangkhamanon
Sakkarn Sangkhamanon
CAChaiwat Aphivatanasiri
Chaiwat Aphivatanasiri
Patients with distal cholangiocarcinoma (dCCA) generally have poor outcomes because of late presentation and diagnosis. Therefore, prognostic factors for predicting outcomes are essential to improve therapeutic strategies and quality of life. Tumor-infiltrating lymphocytes (TILs) have been reported as a prognostic predictor in several cancers. However, their role in dCCA is still unclear. This study aimed to evaluate the association of TILs with outcome in patients with dCCA. Fifty-two patients were evaluated for the percentage rate of TILs in their cancers, and a median TIL level was used to divide the patients into two groups. Survival, multivariate, and correlation analyses were performed to determine the prognostic factors. Results showed that a low TIL level was associated with poor survival. Multivariate analysis revealed TILs as an independent factor for poor outcome. Moreover, TILs were markedly correlated with growth patterns, and both were applied to classify patients with dCCA. Subgroups of TILs with growth pattern incorporation improved stratification performance in separating good from poor patient outcomes. This study suggested that TILs could be a prognostic factor for predicting survival and for clustering patients with dCCA to improve prognostication capability. This finding may be incorporated into a new staging system for stratifying dCCA in Thailand.

5 January 2026 in Medical Sciences
Verified
Journal Article
Open access
PDF file
JCJarin Chindaprasirt
Jarin Chindaprasirt
TSThanachai Sanlung
Thanachai Sanlung
PWPiyakarn Watcharenwong
Piyakarn Watcharenwong
VTVasin Thanasukarn
Vasin Thanasukarn
AJapiwat jarearnrat
apiwat jarearnrat
ATAttapol Titapun
Attapol Titapun
Background: Preoperative inflammatory and nutrition-related markers—including the neutrophil-to-lymphocyte ratio (NLR), lymphocyte-to-monocyte ratio (LMR), prognostic nutritional index (PNI), and controlling nutritional status (CONUT) score—have shown prognostic relevance in various malignancies. However, their comparative utility in predicting recurrence and survival across clinically relevant subgroups in patients with intrahepatic cholangiocarcinoma (iCCA) undergoing curative-intent resection remains unclear. Methods: This retrospective study included 213 patients with histologically confirmed iCCA who underwent curative-intent resection between 2015 and 2021. Preoperative NLR, LMR, PNI, and CONUT scores were calculated from laboratory data obtained within one week before resection. Clinicopathological variables, recurrence, and survival outcomes were analyzed using Cox regression and Kaplan–Meier methods. Results: A preoperative NLR ≥ 2.4 was independently associated with poorer DFS (HR = 1.66, p = 0.025) and OS (HR = 1.94, p = 0.006). This effect remained significant in patients with R0 resection (DFS: HR = 1.66, p = 0.004; OS: HR = 2.11, p = 0.014) and in those who subsequently developed recurrence (OS: HR = 1.83, p = 0.004). The CONUT score was correlated with OS in both R0 and recurrent subgroups. Tumor morphology, consistent with prior reports, was identified as a postoperative pathological factor associated with worse prognosis. Conclusions: Preoperative NLR was associated with poorer DFS and OS in iCCA patients undergoing curative-intent resection. This association was consistently observed in subgroups with R0 resection and in those who developed recurrence. Meanwhile, the CONUT score showed limited independent significance only among patients with R0 resection who experienced recurrence.

4 September 2023
Verified
Book Chapter
Closed access
PDF file
SKSupinda Koonmee
Supinda Koonmee
PSPrakasit Sa-Ngiamwibool
Prakasit Sa-Ngiamwibool
CAChaiwat Aphivatanasiri
Chaiwat Aphivatanasiri
WKWaritta Kunprom
Waritta Kunprom
PIPiyapharom Intarawichian
Piyapharom Intarawichian
MTMalinee Thanee
Malinee Thanee

29 March 2026 in Histopathology
Verified
Journal Article
Open access
MMMonalyn Marabi
Monalyn Marabi
YLYuyang Li
Yuyang Li
CAChaiwat Aphivatanasiri
Chaiwat Aphivatanasiri
JTJulia Y Tsang
Julia Y Tsang
JLJoshua Jing Xi Li
Joshua Jing Xi Li
GTGary Tse
Gary Tse
Aims: De‐escalated treatment for ductal carcinoma in situ (DCIS) aims to prevent overtreatment of patients. However, patients diagnosed preoperatively with pure DCIS via core needle biopsy (CNB) may be upgraded to invasive cancer upon excision. Therefore, it is essential to stratify patients at low risk for upgrade to invasive disease during the biopsy to inform management decisions. Methods and results: In this study, we reviewed a cohort of patients with pure DCIS diagnosed by CNB and their corresponding excision specimens to identify predictive features for upgrading to microinvasion or invasive breast cancer (IBC). Of the 228 CNB cases, 82 (36%) were upgraded at excision, with 26.8% classified as microinvasion and 73.2% as frank invasion. Significant tumour intrinsic features associated with DCIS upgrade included larger tumour size, palpable mass, high grade and presence of necrosis ( P ≤ 0.026). Factors related to sampling adequacy, such as the number of cores, total core length and length of the longest core, were also predictive features ( P ≤ 0.027). Additionally, tumour microenvironment (TME) characteristics, including calcification and stromal tumour‐infiltrating lymphocytes (sTIL), were linked to upgrades, particularly in the human epidermal growth factor 2 (HER2)‐negative subgroup ( P ≤ 0.004). These features were independently associated with frank invasion in HER2‐negative cancers. Conclusions: Our results provide valuable insights into additional predictive features for DCIS upgrade. When combined with adequate sampling and intrinsic tumour characteristics, TME features—namely tumour infiltrating lymphocytes (TILs) and calcification—are useful in predicting DCIS upgrades, especially in HER2‐negative cases.